Bruker Corp
NASDAQ:BRKR

Watchlist Manager
Bruker Corp Logo
Bruker Corp
NASDAQ:BRKR
Watchlist
Price: 58.25 USD 1.5%
Market Cap: 8.8B USD
Have any thoughts about
Bruker Corp?
Write Note

Bruker Corp
Net Issuance of Common Stock

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bruker Corp
Net Issuance of Common Stock Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Issuance of Common Stock CAGR 3Y CAGR 5Y CAGR 10Y
Bruker Corp
NASDAQ:BRKR
Net Issuance of Common Stock
$360.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
47%
Thermo Fisher Scientific Inc
NYSE:TMO
Net Issuance of Common Stock
-$3B
CAGR 3-Years
-17%
CAGR 5-Years
-29%
CAGR 10-Years
N/A
Danaher Corp
NYSE:DHR
Net Issuance of Common Stock
-$5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Mettler-Toledo International Inc
NYSE:MTD
Net Issuance of Common Stock
-$791.1m
CAGR 3-Years
10%
CAGR 5-Years
-5%
CAGR 10-Years
-8%
Agilent Technologies Inc
NYSE:A
Net Issuance of Common Stock
-$1.1B
CAGR 3-Years
-14%
CAGR 5-Years
-10%
CAGR 10-Years
-57%
IQVIA Holdings Inc
NYSE:IQV
Net Issuance of Common Stock
-$493m
CAGR 3-Years
-12%
CAGR 5-Years
17%
CAGR 10-Years
-13%
No Stocks Found

Bruker Corp
Glance View

Market Cap
8.8B USD
Industry
Life Sciences Tools & Services
Economic Moat
None

Bruker Corporation, a prominent entity in the analytical instrumentation sector, traces its roots back to Germany. Wholly devoted to advancing science and industry through meticulous precision, Bruker has carved out a niche in creating sophisticated analytical instruments that enable comprehensive research and diagnostics. Their portfolio spans a diverse range of technologies, including mass spectrometry, magnetic resonance imaging, X-ray analysis, and molecular spectroscopy, all meticulously designed to meet the exacting demands of their clientele. These sophisticated tools empower researchers, scientists, and industrial operators to obtain insights into the fundamental properties of materials and substances, thereby driving forward discoveries in medicine, chemistry, and material science. Bruker's financial health rests on a business model grounded in both innovation and strategic expansion. They generate revenue through the sale of their high-precision instruments as well as a steadily growing service segment that ensures their equipment remains at the cutting edge of functionality and reliability. Additionally, the company pursues collaborative ventures with academic institutions and industrial partners, creating a synergistic loop for product and market development. This strategic approach not only fortifies their market position but also nurtures long-term relationships, underpinning recurring revenues from service contracts and incremental technology upgrades. With a clear focus on driving quality and innovation, Bruker Corporation thrives in a competitive landscape, catering to the evolving needs of scientific discovery and industrial precision.

BRKR Intrinsic Value
68.24 USD
Undervaluation 15%
Intrinsic Value
Price

See Also

What is Bruker Corp's Net Issuance of Common Stock?
Net Issuance of Common Stock
360.1m USD

Based on the financial report for Sep 30, 2024, Bruker Corp's Net Issuance of Common Stock amounts to 360.1m USD.

What is Bruker Corp's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 10Y
47%

Back to Top